A Minnesota House committee on Thursday took up a bill to establish a task force to study and advise on the potential legalization of psychedelics like psilocybin, MDMA and ibogaine.
As lawmakers in the state continue to advance a measure to legalize marijuana, the House Health Finance and Policy Committee agreed to pause further action on the psychedelics reform bill from Rep. Andy Smith (D) after adopting an amendment meant to bolster its bipartisan appeal.
The idea is to hold it over in committee so that it can possibly be incorporated into broader omnibus health legislation that’s in the works.
“We’ve seen many, many studies across the medical community that show these drugs have incredible potential to help with various psychological disorders— whether it’s addiction, whether it is OCD, depression, seasonal depression, trauma health,” Smith said. “There’s a wide range of issues that are incredibly helped with these medicines, and that’s why I think we should really start to look seriously at legalizing these drugs in Minnesota.”
Under the bill, a Psychedelic Medicine Task Force would be established in order to “advise the legislature on the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the
Read full article on Marijuana Moment
